Literature DB >> 8948077

Hemodialysis and hemoperfusion for treatment of valproic acid and gabapentin poisoning.

M C Fernandez1, F G Walter, J C Kloster, S M Do, L A Brady, A Villarin, S J Ruffenach, E H Prosnitz, J V Salmon.   

Abstract

A 31-y-old epileptic man developed coma and shock after suicidally ingesting large amounts of valproic acid and gabapentin. His peak valproic acid, level was 1306.9 micrograms/mL (therapeutic range = 30-100 micrograms/mL). His peak gabapentin level was 60.0 micrograms/mL (therapeutic range = 2.0-8.0 micrograms/mL). His hypotension was refractory to crystalloid and pressor infusions, but resolved during concurrent hemoperfusion and hemodialysis to enhance elimination of valproic acid. Concurrent hemoperfusion and hemodialysis, in series, produced a maximum valproic acid plasma clearance of 55.4 mL/min versus a maximum reported intrinsic valproic acid plasma clearance of 10.6 mL/min. concurrent hemoperfusion and hemodialysis, in series, should be considered in hemodynamically unstable patients with valproic acid poisoning whose clinical condition is worsening in spite of aggressive supportive care.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8948077

Source DB:  PubMed          Journal:  Vet Hum Toxicol        ISSN: 0145-6296


  1 in total

1.  Valproate-Induced Hyperammonemic Encephalopathy Following Accidental Ingestion in a Toddler.

Authors:  Moftah Alhagamhmad; Aisha Elarwah; Alia Alhassony; Shirin Alougly; Hamza Milad; Aziza Dehoam; Suliman Elbrgathy; Nuri Shembesh; Emhemed Mousa; Abdulhamid ElShiky
Journal:  J Pediatr Pharmacol Ther       Date:  2021-02-15
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.